Exactech, Inc. (NASDAQ:EXAC) has been assigned a consensus recommendation of “Hold” from the seven ratings firms that are presently covering the company, MarketBeat reports. Six equities research analysts have rated the stock with a hold recommendation. The average 1 year target price among brokerages that have covered the stock in the last year is $49.00.

Several analysts recently issued reports on the company. Robert W. Baird set a $34.00 target price on Exactech and gave the stock a “buy” rating in a report on Sunday, October 15th. Zacks Investment Research lowered Exactech from a “hold” rating to a “sell” rating in a report on Wednesday, October 25th. Gabelli lowered Exactech from a “buy” rating to a “hold” rating in a report on Tuesday, October 24th. Sidoti lowered Exactech from a “buy” rating to a “neutral” rating in a report on Monday, October 23rd. Finally, ValuEngine lowered Exactech from a “buy” rating to a “hold” rating in a report on Friday, December 1st.

Exactech (NASDAQ EXAC) traded up $1.15 on Monday, reaching $50.50. The company had a trading volume of 326,889 shares, compared to its average volume of 130,660. Exactech has a fifty-two week low of $23.30 and a fifty-two week high of $50.95. The company has a market capitalization of $711.30, a price-to-earnings ratio of 2,525.00, a PEG ratio of 3.65 and a beta of 1.02. The company has a quick ratio of 2.09, a current ratio of 4.08 and a debt-to-equity ratio of 0.06.

Exactech (NASDAQ:EXAC) last released its earnings results on Monday, October 30th. The medical equipment provider reported $0.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.23 by ($0.03). Exactech had a return on equity of 7.22% and a net margin of 0.18%. The company had revenue of $61.40 million for the quarter, compared to the consensus estimate of $61.78 million. equities research analysts anticipate that Exactech will post 1.29 earnings per share for the current year.

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. The Manufacturers Life Insurance Company increased its position in Exactech by 3.2% during the second quarter. The Manufacturers Life Insurance Company now owns 9,323 shares of the medical equipment provider’s stock worth $278,000 after buying an additional 289 shares during the last quarter. Teachers Advisors LLC increased its position in Exactech by 2.7% during the second quarter. Teachers Advisors LLC now owns 21,549 shares of the medical equipment provider’s stock worth $642,000 after buying an additional 568 shares during the last quarter. California Public Employees Retirement System increased its position in Exactech by 4.5% during the second quarter. California Public Employees Retirement System now owns 23,100 shares of the medical equipment provider’s stock worth $688,000 after buying an additional 1,000 shares during the last quarter. Numeric Investors LLC increased its position in Exactech by 4.4% during the second quarter. Numeric Investors LLC now owns 30,643 shares of the medical equipment provider’s stock worth $913,000 after buying an additional 1,300 shares during the last quarter. Finally, Alliancebernstein L.P. increased its position in Exactech by 6.1% during the second quarter. Alliancebernstein L.P. now owns 24,456 shares of the medical equipment provider’s stock worth $729,000 after buying an additional 1,400 shares during the last quarter. 66.30% of the stock is currently owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY NOTICE: “Exactech, Inc. (EXAC) Given Consensus Rating of “Hold” by Brokerages” was reported by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of US & international copyright legislation. The legal version of this piece of content can be accessed at https://www.americanbankingnews.com/2018/01/08/exactech-inc-exac-given-consensus-rating-of-hold-by-brokerages.html.

Exactech Company Profile

Exactech, Inc develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company’s segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines.

Receive News & Ratings for Exactech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exactech and related companies with MarketBeat.com's FREE daily email newsletter.